A comprehensive view of women's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Merck and Eisai announces approval in Japan for intravenous KEYTRUDA plus oral LENVIMA for treatment of certain endometrial carcinomas
Published:
December 27, 2021
by Merck & Co. Inc.
|
Evotec announces US$18M grant from the Bill & Melinda Gates Foundation for discovery and development of novel pharmaceuticals in women's health and contraceptive technology
Published:
December 16, 2021
by Evotec AG
|
Merck announces European Commission approval of Keytruda with oral Lenvima for treatment of certain endometrial cancers
Published:
November 30, 2021
by Merck & Co. Inc.
|
Bayer to invest more than €400M to increase access to modern contraception for women in low- and middle-income countries; plans include production expansions in Turku, Finland, and a new site in Alajuela, Costa Rica
Published:
October 05, 2021
by Bayer AG
|
Abbott announces creation of the Abbott Center for Malnutrition Solutions, an innovation hub focused on reducing malnutrition around the world; company aims to create solutions for vulnerable populations including children, mothers and the elderly
Published:
September 30, 2021
by Abbott Laboratories
|
Ask us about our Consumer Wellness market view